Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P-TEV in Chronic Venous Insufficiency
NCT03784131Phase 1Completed
- Sponsor
- VERIGRAFT
- Start
- Dec 2021
- Primary completion
- Jun 2025
- Modality
- Implantable Devices, Implantable Hydrogels, Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of P-TEV in chronic venous insufficiency (CVI), sponsored by VERIGRAFT. Primary endpoints: Thrombosis leading to occlusion of the graft at 12 months, Infection leading to surgical excision of the graft at 12 months and 1 more. Started Dec 2021; status: completed.
02
Drugs
P-TEV
03
Conditions
chronic venous insufficiency (CVI)
Beyond the preview
Go deeper on NCT03784131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03784131.